Literature DB >> 18228421

Fragmentation of immunoglobulin G.

Sarah M Andrew1, Julie A Titus.   

Abstract

For some purposes, fragments of the IgG molecule are preferred. The F(c) portion is useful for studies of biological effect-binding to the F(c) receptor, mediating antibody-dependent cellular cytotoxicity, and complement fixation. The bivalent F(ab')(2) produced by digestion with pepsin and the monovalent Fab produced by digestion with papain are useful for studies based on the interaction between antibody binding site(s) with antigen. This unit also describes alternative methods for preparing F(ab')(2) fragments.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 18228421     DOI: 10.1002/0471143030.cb1604s17

Source DB:  PubMed          Journal:  Curr Protoc Cell Biol        ISSN: 1934-2616


  6 in total

1.  Ligand association rates to the inner-variable-domain of a dual-variable-domain immunoglobulin are significantly impacted by linker design.

Authors:  Enrico L Digiammarino; John E Harlan; Karl A Walter; Uri S Ladror; Rohinton P Edalji; Charles W Hutchins; Marc R Lake; Amy J Greischar; Junjian Liu; Tariq Ghayur; Clarissa G Jakob
Journal:  MAbs       Date:  2011-09-01       Impact factor: 5.857

Review 2.  Considerations for the Design of Antibody-Based Therapeutics.

Authors:  Dennis R Goulet; William M Atkins
Journal:  J Pharm Sci       Date:  2019-06-04       Impact factor: 3.534

3.  Evaluation of Fab and F(ab')2 fragments and isotype variants of a recombinant human monoclonal antibody against Shiga toxin 2.

Authors:  Donna E Akiyoshi; Abhineet S Sheoran; Curtis M Rich; L Richard; Susan Chapman-Bonofiglio; Saul Tzipori
Journal:  Infect Immun       Date:  2010-01-19       Impact factor: 3.441

4.  Phagocytosis of Staphylococcus aureus by human neutrophils prevents macrophage efferocytosis and induces programmed necrosis.

Authors:  Mallary C Greenlee-Wacker; Kevin M Rigby; Scott D Kobayashi; Adeline R Porter; Frank R DeLeo; William M Nauseef
Journal:  J Immunol       Date:  2014-04-11       Impact factor: 5.422

5.  Site-specific modification of ED-B-targeting antibody using intein-fusion technology.

Authors:  Sina Möhlmann; Peter Bringmann; Simone Greven; Axel Harrenga
Journal:  BMC Biotechnol       Date:  2011-07-21       Impact factor: 2.563

6.  Side-by-Side Comparison of Commonly Used Biomolecules That Differ in Size and Affinity on Tumor Uptake and Internalization.

Authors:  Jeerapond Leelawattanachai; Keon-Woo Kwon; Praveesuda Michael; Richard Ting; Ju-Young Kim; Moonsoo M Jin
Journal:  PLoS One       Date:  2015-04-22       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.